Soleno Therapeutics, Inc. Gains 103.86%
Mon, Dec 19, 2022 at 07:02 PM
Soleno Therapeutics, Inc. (SLNO:NASDAQ) shot up at $1.85, a gain of 103.9%. On Mon, Dec 19, 2022, SLNO:NASDAQ touched a New 2-Week High of $1.85. The stock appeared on our News Catalysts scanner on Mon, Dec 19, 2022 at 09:24 AM in the 'INVESTOR UPDATE' category. From Mon, Dec 05, 2022, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Dec 19, 2022 at $2.42 with a volume of 104M+.
About Soleno Therapeutics, Inc. (SLNO:NASDAQ)
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Top 10 Gainers:
- Starry Group Holdings Inc. Class A (STRY:NYSE), 581.82%
- Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ), 268.07%
- Axcella Health Inc. (AXLA:NASDAQ), 165.27%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 103.86%
- Qumu Corporation (QUMU:NASDAQ), 100%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 73.88%
- Camber Energy, Inc. (CEI:NYSEMKT), 72.9%
- Landos Biopharma Inc. (LABP:NASDAQ), 56.31%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 49.26%